✦ LIBER ✦

NEW BASIC PATHOPHYSIOLOGY PARADIGM TO EXPLAIN THE ETIOLOGY OF LOWER URINARY TRACT SYMPTOMS AND THE POTENTIAL OF PDE5 INHIBITORS FOR TREATMENT OF VOID DYSFUNCTION

✍ Scribed by Oliveira, Ricardo; D'Ancona, Carlos; Medeiros, Clarissa; Monica, Fabiola; Antunes, Edson

Book ID: 122886770
Publisher: Lippincott Williams and Wilkins
Year: 2008
Tongue: English
Weight: 270 KB
Volume: 179
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(08)62046-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Efficacy of PDE5 Inhibitors Alone or

The Efficacy of PDE5 Inhibitors Alone or in Combination with Alpha-Blockers for the Treatment of Erectile Dysfunction and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis

✍ Yan, Huilei (author);Zong, Huantao (author);Cui, Yuanshan (author);Li, Nan (auth 📂 Article 📅 2014 🏛 Blackwell Publishing Ltd 🌐 English ⚖ 460 KB

The Efficacy of PDE5 Inhibitors Alone or

✍ Yan, Huilei (author);Zong, Huantao (author);Cui, Yuanshan (author);Li, Nan (auth 📂 Article 📅 2014 🏛 Blackwell Publishing Ltd 🌐 English ⚖ 460 KB

Tadalafil for the treatment of lower uri

Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action

✍ Karl-Erik Andersson; William C. de Groat; Kevin T. McVary; Tom F. Lue; Mario Mag 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 1 views

1253 A SYSTEMATIC REVIEW AND META-ANALYS

1253 A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE USE OF PHOSPHODIESTERASE TYPE 5 INHIBITORS (PDE5-IS) FOR LOWER URINARY TRACT SYMPTOMS (LUTS) SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH)

✍ Gacci, Mauro; Corona, Giovanni; Salvi, Matteo; Vignozzi, Linda; McVary, Kevin T. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 112 KB

644 Systematic review and meta-analysis

644 Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors (pde5-is) alone or in combination with alpha blockers for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

✍ M. Gacci; G. Corona; M. Salvi; L. Vignozzi; K.T. McVary; S.A. Kaplan; C.G. Roehr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 17 KB

Reply to Jin-Qiu Yuan, Zu-Yao Yang, and

Reply to Jin-Qiu Yuan, Zu-Yao Yang, and Chen Mao's Letter to the Editor re: Mauro Gacci, Giovanni Corona, Matteo Salvi, et al. A Systematic Review and Meta-Analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Eur Urol 2012;61:994–1003: Meta-analysis on the Use of PDE5 Inhibitors for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia, According to the Recommendations of the Cochrane

✍ Mauro Gacci; Giovanni Corona; Matteo Monami; Sergio Serni; Vincenzo Mirone; Marc 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 142 KB